Indian companies reported a mixed set of second-quarter results on Tuesday, October 27. Cipla’s profit declined, while several companies across pharmaceuticals, jewellery, chemicals and manufacturing reported year-on-year growth. Figures are in ₹ crore, rounded to the nearest crore, and YoY compares the September 2026 quarter with the September 2025 quarter.
In Simple Words: What These Results Mean
Every three months, listed companies tell investors how much they sold (revenue) and how much they earned after all costs (net profit). Comparing this quarter with the same quarter last year (YoY) shows whether a business is growing. Today, nine of the ten companies earned more profit than a year ago, and Cipla was the exception. When revenue and profit both rise, the business is generally growing well. When profit rises much faster than revenue, costs are being managed better. A very big jump, like OneSource’s, often starts from a very small base, so it looks larger than it is. Cipla’s lower profit was partly linked to weaker overseas sales.
Cipla: Lower Revenue and Profit
Cipla’s consolidated revenue declined year on year, while net profit fell more sharply. The company attributed part of the revenue comparison to a reporting change that moved certain marketing and promotional expenses from other expenses to deductions from revenue, and said it did not affect profit or cash flow. Weaker North American revenue, with moderation in generic Revlimid sales, weighed on the overseas business, while India grew.
| ₹ crore (Consolidated) | Q2 FY27 | Q2 FY26 | YoY |
|---|---|---|---|
| Revenue | 7,404 | 7,589 | -2.4% |
| Net profit | 878 | 1,351 | -35% |
Acutaas Chemicals: Profit Up 86%
Acutaas Chemicals reported strong growth on a standalone basis, with profit rising faster than revenue.
Also Read: Sensex, Nifty Today, October 28: IT Stocks Weigh as Bank Nifty and Midcaps Gain
| ₹ crore (Standalone) | Q2 FY27 | Q2 FY26 | YoY |
|---|---|---|---|
| Revenue | 433 | 305 | +41% |
| Net profit | 136 | 73 | +86% |
OneSource Specialty Pharma: Profit Jumps From Low Base
OneSource Specialty Pharma recorded a particularly large percentage increase in profit from a low year-ago base.
| ₹ crore (Consolidated) | Q2 FY27 | Q2 FY26 | YoY |
|---|---|---|---|
| Revenue | 516 | 376 | +37% |
| Net profit | 57 | 10 | +470% |
Sky Gold and Diamonds: Revenue Up 61%
Sky Gold and Diamonds posted growth in both revenue and net profit.
| ₹ crore (Consolidated) | Q2 FY27 | Q2 FY26 | YoY |
|---|---|---|---|
| Revenue | 2,391 | 1,484 | +61% |
| Net profit | 129 | 67 | +92% |
Jubilant Ingrevia: Profit Up 58%
Jubilant Ingrevia reported higher revenue and a faster rise in net profit.
| ₹ crore (Consolidated) | Q2 FY27 | Q2 FY26 | YoY |
|---|---|---|---|
| Revenue | 1,394 | 1,121 | +24% |
| Net profit | 111 | 70 | +58% |
Morepen Laboratories: Revenue and Profit Higher
Morepen Laboratories reported higher revenue and profit on a consolidated basis, with profit more than doubling.
Also Read: GIFT Nifty Today, October 28, 2026: Opening Indication, Nifty Gap and Key Levels
| ₹ crore (Consolidated) | Q2 FY27 | Q2 FY26 | YoY |
|---|---|---|---|
| Revenue | 747 | 412 | +81% |
| Net profit | 89 | 41 | +117% |
Vardhman Special Steels: Profit Up 48%
Vardhman Special Steels reported higher year-on-year revenue and net profit.
| ₹ crore (Standalone) | Q2 FY27 | Q2 FY26 | YoY |
|---|---|---|---|
| Revenue | 600 | 432 | +38% |
| Net profit | 52 | 35 | +48% |
Bharat Bijlee: Profit Up 64%
Bharat Bijlee recorded faster profit growth than revenue growth.
| ₹ crore (Standalone) | Q2 FY27 | Q2 FY26 | YoY |
|---|---|---|---|
| Revenue | 736 | 473 | +55% |
| Net profit | 46 | 28 | +64% |
Dynamic Cables: Modest Profit Growth
Dynamic Cables’ profit growth was more modest than its revenue growth.
| ₹ crore (Standalone) | Q2 FY27 | Q2 FY26 | YoY |
|---|---|---|---|
| Revenue | 363 | 282 | +28% |
| Net profit | 22 | 20 | +10% |
Bharat Seats: Profit Up 50%
Bharat Seats reported higher year-on-year revenue and net profit.
Also Read: Stocks to Watch Today, October 28, 2026: L&T, Maruti Suzuki, Waaree Energies and More
| ₹ crore (Standalone) | Q2 FY27 | Q2 FY26 | YoY |
|---|---|---|---|
| Revenue | 709 | 459 | +54% |
| Net profit | 15 | 10 | +50% |
The October 27 results show a varied earnings picture: Cipla faced a year-on-year decline, while the other companies in this roundup reported profit growth.
Disclaimer: This article is for informational purposes only and is not investment advice. OneTrader is not registered with SEBI as an investment adviser or research analyst.
Keep learning with OneTrader
Explore structured lessons and practical guides to build your market knowledge.
